224 related articles for article (PubMed ID: 26351429)
1. Elderly-Onset Generalized Pustular Psoriasis without a Previous History of Psoriasis Vulgaris.
Aizu T; Matsui A; Takiyoshi N; Akasaka E; Kaneko T; Nakano H; Sugiura K; Akiyama M; Sawamura D
Case Rep Dermatol; 2015; 7(2):187-93. PubMed ID: 26351429
[TBL] [Abstract][Full Text] [Related]
2. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
3. Generalized pustular psoriasis in a 92-year-old man with a homozygous nonsense mutation in IL36RN.
Ueda Y; Komine M; Kamiya K; Tsuda H; Maekawa T; Murata S; Ohtsuki M
J Dermatol; 2018 Mar; 45(3):326-328. PubMed ID: 29215143
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
[TBL] [Abstract][Full Text] [Related]
5. A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis.
Tominaga C; Yamamoto M; Imai Y; Yamanishi K
Case Rep Dermatol; 2015; 7(1):29-35. PubMed ID: 25848350
[TBL] [Abstract][Full Text] [Related]
6. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
Zhu T; Jin H; Shu D; Li F; Wu C
Eur J Dermatol; 2018 Apr; 28(2):217-224. PubMed ID: 29619998
[TBL] [Abstract][Full Text] [Related]
7. The genetic basis for most patients with pustular skin disease remains elusive.
Mössner R; Wilsmann-Theis D; Oji V; Gkogkolou P; Löhr S; Schulz P; Körber A; Prinz JC; Renner R; Schäkel K; Vogelsang L; Peters KP; Philipp S; Reich K; Ständer H; Jacobi A; Weyergraf A; Kingo K; Kõks S; Gerdes S; Steinz K; Schill T; Griewank KG; Müller M; Frey S; Ebertsch L; Uebe S; Sticherling M; Sticht H; Hüffmeier U
Br J Dermatol; 2018 Mar; 178(3):740-748. PubMed ID: 28887889
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
[TBL] [Abstract][Full Text] [Related]
9. Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases.
Yoshikawa M; Rokunohe D; Kimura A; Takahashi M; Korekawa A; Nakajima K; Nakano H; Yokoyama M; Tanaka K; Yokoyama Y; Sawamura D
J Dermatol; 2021 May; 48(5):699-702. PubMed ID: 33599999
[TBL] [Abstract][Full Text] [Related]
10. Correlation of IL36RN and CARD14 mutations with clinical manifestations and laboratory findings in patients with generalised pustular psoriasis.
Trai NN; Van Em D; Van BT; My LH; Van Tro C; Hao NT; Vu HA; Tram DB; Van Thuong N; Doanh LH
Indian J Dermatol Venereol Leprol; 2023; 89(3):378-384. PubMed ID: 36331855
[TBL] [Abstract][Full Text] [Related]
11. Acute generalized exanthematous pustulosis caused by dihydrocodeine phosphate in a patient with psoriasis vulgaris and a heterozygous IL36RN mutation.
Nakai N; Sugiura K; Akiyama M; Katoh N
JAMA Dermatol; 2015 Mar; 151(3):311-5. PubMed ID: 25409173
[TBL] [Abstract][Full Text] [Related]
12. Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.
Kanazawa N; Nakamura T; Mikita N; Furukawa F
J Dermatol; 2013 Sep; 40(9):749-51. PubMed ID: 23834760
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris.
Li X; Chen M; Fu X; Zhang Q; Wang Z; Yu G; Yu Y; Qin P; Wu W; Pan F; Liu H; Zhang F
J Dermatol Sci; 2014 Nov; 76(2):132-8. PubMed ID: 25212972
[TBL] [Abstract][Full Text] [Related]
14. A homozygous loss-of-function variant in the MPO gene is associated with generalized pustular psoriasis.
Onitsuka M; Farooq M; Iqbal MN; Yasuno S; Shimomura Y
J Dermatol; 2023 May; 50(5):664-671. PubMed ID: 36585391
[TBL] [Abstract][Full Text] [Related]
15. Increased neutrophil-derived IL-17A identified in generalized pustular psoriasis.
Lan Y; Wu X; Zhong X; Song P; Liu L; Liu Y; Ai X; Han C; Zhang Z
Exp Dermatol; 2024 Feb; 33(2):e15026. PubMed ID: 38414093
[TBL] [Abstract][Full Text] [Related]
16. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
17. A Case of Ceftriaxone-Induced Acute Generalized Exanthematous Pustulosis/Generalized Pustular Psoriasis Overlap.
Zheng J; Gao Y; Yi X; Ding Y
Case Rep Dermatol; 2018; 10(1):69-75. PubMed ID: 29681811
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of generalized pustular psoriasis.
Iizuka H; Takahashi H; Ishida-Yamamoto A
Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S55-9. PubMed ID: 12677433
[TBL] [Abstract][Full Text] [Related]
19. Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects.
Takeichi T; Akiyama M
Am J Clin Dermatol; 2020 Apr; 21(2):227-236. PubMed ID: 31813117
[TBL] [Abstract][Full Text] [Related]
20. Infantile generalized pustular psoriasis: successful disease control with intermittent etretinate.
Namba C; Murakami M; Hanakawa Y; Tohyama M; Shirakata Y; Tauchi H; Sayama K
J Dermatol; 2014 May; 41(5):403-6. PubMed ID: 24801915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
